Synthesis of Novel 6-Cyano-9-(aryl)-9H-purine Derivatives
221
4-Hydroxy-(Z)-N-[2-amino-1,2-dicyanovinyl]formamidine (3d)
o
(94%), Pale green, mp 130 C; MS: m
/
z 227 (M)+; IR (KBr): 3450, 3325, 3200, 3100,
2900, 2400, 1645, 1590, 1570, 1510, 1420, 1360, 1320, 960, 820, 750 cm-1; H NMR
(DMSO-d6) δ 9.72 (s, 1H, NH), 9.22 (s, 1H, CH), 7.64 (d, 2H, Ar-H), 6.72 (s, 2H, Ar-
H), 6.28 (s, 2H, NH2). Anal. Calcd. for C11H9N5O: C, 58.14; H, 3.96; N, 30.83. Found:
C, 57.98; H, 4.01; N, 30.39.
1
General procedure for the preparation of the 6-cyano-9-(aryl)-9H-purine (4a-d)
The mixture of formamidine (3a-d) (0.40 mmol) and triethyl orthoformate (3 mL,
6.33 mmol) were heated at reflux temperature for 6 hours until TLC (8:2, ethylacetate /
petroleum ether) showed that all the formamidine (3a-d) had disappeared and the 9-substituted
cyanopurines (3a-d) was isolated by filtration. The most cases the product was grey. The
precipitate was washed with dry petroleum ether and air-dried. Obtained precipitates were
recrystallized by ethanol to give the analytically pure product.
6-Cyano-9-(4-ethoxyphenyl)-9H-purine (4a)
o
(70%), Pale gray, mp 182-184 C; MS : m
/
z 265 (M)+; IR (KBr): 3100, 2900, 2380, 1590,
1475, 1510, 1340, 1440, 1350 cm-1; H NMR (DMSO-d6) δ 9.18 (s, 1H, H (Pyrimidine)),
9.09 (s, 1H, H (Imidazole)), 7.69 (d, J = 8.89 Hz, 2H, Ar-H), 7.10 (d, J = 8.92 Hz, 2H, Ar-H),
4.07 (q, J = 6.93 Hz, 2H, CH2), 1.33 (t, J = 6.93 Hz, 3H, CH3). Anal. Calcd. for
C14H11N5O: C, 63.39; H, 4.15; N, 26.41. Found:C, 62.40; H, 4.16; N, 26.36.
1
1,4-Phenylen-bis[9N,9N'-6-cyano-9H]purine (4b)
o
(71.1%), green, mp > 340 C; MS : m
/
z 364.40 (M)+; IR (KBr): 3100, 2350, 1510, 1590,
1400, 1350 cm-1; H NMR (DMSO-d6) δ 9.41 (s, 2H, H (Pyrimidine)), 9.20 (s, 2H, H
(Imidazole)), 8.19 (s, 4H, Ar-H). Anal. Calcd. for C18H8N10: C, 59.34; H, 2.23; N, 47.45.
Found: C, 60.02; H, 2.23; N, 47.45.
1
6-Cyano-9-(2-methoxybenzyl)-9H-purine (4c)
(80.40%), Gray, mp 147-150 oC; MS : m z 293 (M)+; IR (KBr): 3100, 2900, 2380, 1590,
/
1485, 1460, 1400, 1320, 1440, 1380 cm-1; 1H NMR (CDCl3-d1) δ 9.06 (s, 1H, H
(Pyrimidine)), 8.35 (s, 1H, H (Imidazole)), 7.43 (d, J = 7.38 Hz, 1H, Ar-H), 7.35 (t, J = 7.94
Hz, 1H, Ar-H), 6.97 (t, J = 7.47 Hz, 1H, Ar-H), 6.92 (d, J = 8.28 Hz, 1H, Ar-H), 5.46 (s, 2H,
CH2), 3.87 (s, 3H, OCH3). Anal. Calcd. for C14H11N5O: C, 57.33; H, 3.75; N, 23.89. Found:
C, 56.08; H, 3.70; N, 24.07.
6-Cyano-9-(4-hydroxy)-9H-purine (4d)
(75%), Brown, mp 208-210 oC; MS: m
/
z 237 (M)+; IR (KBr): 3200, 2380, 1500, 1460, 1400,
1
1320 cm-1; H NMR (DMSO-d6) δ 10.00 (s, 1H, OH), 9.15 (s, 1H, H (Pyrimidine)), 9.11
(s, 1H, H (Imidazole)), 7.59 (d, J = 8.75 Hz, 2H, Ar-H), 6.95 (d, J = 8.79 Hz, 2H, Ar-H).
Anal. Calcd. for C12H7N5O:C, 60.75; H, 2.95; N, 29.53. Found: C, 59.90; H, 2.99; N, 29.95.
Results and Discussion
Formimidate (2) was prepared in high yield from diaminomaleonitrile (1) and triethyl
orthofarmate, according to a previously described procedure27. Having obtained the imidate (2)
in good yield it was then treated with aryl or benzylamine in a 1:1 or 1:2 molar ratio in dry
ethanol in the presence of a catalytic amount of anilinium chloride and argon atmospheres.
These compounds would be important intermediates